Synapse - Advanced Practice Providers

Results (237)

Allogeneic matched related donor bone marrow transplantation for pediatric patients with severe aplastic anemia using "low-dose" cyclophosphamide, ATG plus fludarabine

Journal Article

Takpradit, C.; Prockop, S. E.; Kernan, N. A.; Scaradavou, A.; Curran, K.; Ruggiero, J.; Zakak, N.; O'Reilly, R. J.; Boulad, F.
Journal of Pediatric Hematology/Oncology (2018)

Fulltext@MSK | Save

Rituximab use, immune reconstitution, and vaccination after ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (HCT)

Meeting Abstract

Preston, E. V.; Malard, F.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; Smith, K.; Maslak, P.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

A phase II study of radioimmunotherapy with intraventricular (131)I-3F8 for medulloblastoma

Journal Article

Kramer, K.; Pandit-Taskar, N.; Humm, J. L.; Zanzonico, P. B.; Haque, S.; Dunkel, I. J.; Wolden, S. L.; Donzelli, M.; Goldman, D. A.; Lewis, J. S.; more...
Pediatric Blood and Cancer (2018)

Fulltext@MSK | Save

A phase I study of convection enhanced delivery (CED) of (124)I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma (DIPG)

Meeting Abstract

Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Zanzonico, P.; Zhou, Z.; Donzelli, M.; Lyashchenko, S. K.; Haque, S.; Thakur, S. B.; Cheung, N. K. V.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy

Meeting Abstract

Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Carbone, E.; Fernandez, C.; Chen, Y.; Autio, K. A.; Rathkopf, D. E.; Kampel, L.; Morris, M. J.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Biomarkers associated with neurotoxicity in adult patients with relapsed or refractory B-ALL (R/R B-ALL) treated with CD19 CAR T cells

Meeting Abstract

Santomasso, B.; Park, J. H.; Riviere, I.; Mead, E.; Halton, E.; Diamonte, C.; Purdon, T.; Senechal, B.; Li, D.; Sadelain, M.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

A phase I trial of CD19-targeted EGFRt/19-28z/4-1BBL armored chimeric antigen receptor (CAR) modified T cells in patients with relapsed or refractory chronic lymphocytic leukemia

Meeting Abstract

Park, J. H.; Riviere, I.; Wang, X.; Senechal, B.; Bernal, Y.; Halton, E.; Diamonte, C.; Wang, Y.; Brentjens, R. J.; Sadelain, M.
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Durable long-term survival of adult patients with relapsed B-ALL after CD19 CAR (19-28z) T-cell therapy

Meeting Abstract

Park, J. H.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Mead, E.; Santomasso, B.; Halton, E.; Diamonte, C.; Bernal, Y.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Baseline and early post-treatment clinical and laboratory factors associated with severe neurotoxicity following 19-28z CAR T cells in adult patients with relapsed B-ALL

Meeting Abstract

Park, J. H.; Santomasso, B.; Riviere, I.; Senechal, B.; Wang, X.; Purdon, T.; Wang, Y.; Halton, E.; Diamonte, C.; Li, D.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM

Meeting Abstract

Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
Blood (2017)

Fulltext@MSK | Save